1 / 7

Women’s Health Initiative Hormone Trials

Women’s Health Initiative Hormone Trials. Charles Kooperberg, et al. PLoS Clin Trials 2(6): e28. Baseline Characteristics by Case-Control Status and Hormone Trial – Part I. Charles Kooperberg, et al. PLoS Clin Trials 2(6): e28.

skip
Télécharger la présentation

Women’s Health Initiative Hormone Trials

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Women’s Health Initiative Hormone Trials Charles Kooperberg, et al. PLoS Clin Trials 2(6): e28

  2. Baseline Characteristics by Case-Control Status and Hormone Trial – Part I Charles Kooperberg, et al. PLoS Clin Trials 2(6): e28

  3. Baseline Characteristics by Case-Control Status and Hormone Trial – Part II Charles Kooperberg, et al. PLoS Clin Trials 2(6): e28

  4. Risk of Ischemic Stroke for Baseline Biomarkers: Highest Quartile versus Lowest Quartile Charles Kooperberg, et al. PLoS Clin Trials 2(6): e28

  5. Ischemic Stroke Risk with Baseline Biomarker by Treatment Assignment Charles Kooperberg, et al. PLoS Clin Trials 2(6): e28

  6. Changes in Biomarkers from Baseline to Year 1 Charles Kooperberg, et al. PLoS Clin Trials 2(6): e28

  7. Ischemic Stroke Risk by Treatment Assignment Modified by Change in Biomarker, Baseline to Year 1 Charles Kooperberg, et al. PLoS Clin Trials 2(6): e28

More Related